1 Safe-and-Steady Stock with Exciting Potential and 2 Facing Headwinds

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Choosing the wrong investments can cause you to fall behind, which is why we started StockStory - to separate the winners from the losers. Keeping that in mind, here is one low-volatility stock that could succeed under all market conditions and two stuck in limbo.

Two Stocks to Sell:

Moog (MOG.A)

Rolling One-Year Beta: 0.78

Responsible for the flight control actuation system integrated in the B-2 stealth bomber, Moog (NYSE:MOG.A) provides precision motion control solutions used in aerospace and defense applications

Why Is MOG.A Not Exciting?

1. 4.9% annual revenue growth over the last five years was slower than its industrials peers
2. Free cash flow margin dropped by 6.6 percentage points over the last five years, implying the company became more capital intensive as competition picked up
3. ROIC of 8% reflects management’s challenges in identifying attractive investment opportunities

At $251.04 per share, Moog trades at 26.5x forward P/E. If you’re considering MOG.A for your portfolio, see our FREE research report to learn more.

Waters Corporation (WAT)

Rolling One-Year Beta: 0.66

Founded in 1958 and pioneering innovations in laboratory analysis for over six decades, Waters (NYSE:WAT) develops and manufactures analytical instruments, software, and consumables for liquid chromatography, mass spectrometry, and thermal analysis used in scientific research and quality testing.

Why Does WAT Worry Us?

1. Sales trends were unexciting over the last two years as its 1.8% annual growth was below the typical healthcare company
2. Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
3. Eroding returns on capital suggest its historical profit centers are aging

Waters Corporation’s stock price of $383.25 implies a valuation ratio of 27.7x forward P/E. Dive into our free research report to see why there are better opportunities than WAT.

One Stock to Buy:

Humana (HUM)

Rolling One-Year Beta: 0.81

With over 80% of its revenue derived from federal government contracts, Humana (NYSE:HUM) provides health insurance plans and healthcare services to approximately 17 million members, with a strong focus on Medicare Advantage plans for seniors.

Why Is HUM a Top Pick?

1. Offerings and unique value proposition resonate with customers, as seen in its above-market 12.8% annual sales growth over the last two years
2. Dominant market position is represented by its $126.3 billion in revenue, which gives it negotiating power over membership pricing and reimbursement rates
3. Stellar returns on capital showcase management’s ability to surface highly profitable business ventures

Humana is trading at $256.95 per share, or 19.1x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free for active Edge members.

High-Quality Stocks for All Market Conditions

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today.